BioHorizons, which sells dental implants and biologics for the replacement of missing teeth, postponed its IPO on Thursday. The Birmingham, AL-based company, which was founded in 1995 and booked $79 million in sales for the 12 months ended September 30, 2010, had expected to raise $90 million by offering 5.6 million shares at a price range of $15-$17. Piper Jaffray and Jefferies & Co. were set to be the lead underwriters on the deal.
